Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2021-03-11 2021-04-29 135561
NV-CLINDAMYCIN 150MG CAPSULE Resolved 2025-10-01 2025-10-01 268159
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, EXTENDED-RELEASE KIT Resolved 2022-03-04 2022-03-24 156070
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-17 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2022-08-18 2024-06-13 166975
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-11 2024-11-08 240046
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-10-17 2025-01-30 240525
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2024-11-28 2025-05-30 244081
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-01-09 2025-11-06 247309
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Resolved 2025-07-29 2025-08-29 263746
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2025-09-19 2025-11-13 267502
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1746
ONDANSETRON INJECTION 2MG SOLUTION Actual shortage 2017-03-13 2017-10-05 1754
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-18 2019-08-06 86905
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-18 2019-07-16 86908
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-06-27 2019-08-21 87684
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-12 2019-11-22 93650
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2019-09-26 2019-11-14 94840
OXALIPLATIN INJECTION 5MG SOLUTION Resolved 2020-02-21 2020-05-08 106955

Showing 521 to 540 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-ARIPIPRAZOLE 10MG TABLET Discontinued 2020-06-11 2020-06-11 117535
TEVA-ARIPIPRAZOLE 15MG TABLET Discontinued 2020-06-11 2020-06-11 117538
TEVA-ARIPIPRAZOLE 30MG TABLET Discontinued 2020-06-11 2020-06-11 117541
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
TEVA-ATENOLOL/CHLORTHALIDONE 25MG 100MG TABLET Discontinued 2020-01-21 2020-01-21 103781
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64538
TEVA-ATORVASTATIN 40MG TABLET Discontinued 2018-10-17 2018-10-17 64541
TEVA-ATORVASTATIN 10MG TABLET Discontinued 2018-10-17 2018-10-17 64601
TEVA-ATORVASTATIN 10MG TABLET Discontinued 2018-10-17 2018-10-17 64606
TEVA-ATORVASTATIN 20MG TABLET Discontinued 2018-10-17 2018-10-17 64609
TEVA-ATORVASTATIN 20MG TABLET Discontinued 2018-10-17 2018-10-17 64612
TEVA-ATORVASTATIN 80MG TABLET Reversed 2025-05-28 2025-06-04 258655
TEVA-AZATHIOPRINE 50MG TABLET Discontinued 2025-05-28 2025-05-28 258613
TEVA-AZITHROMYCIN 250MG TABLET Discontinued 2025-04-25 2025-04-25 255821
TEVA-AZITHROMYCIN 250MG TABLET Discontinued 2025-05-28 2025-05-28 258541
TEVA-BETAHISTINE 8MG TABLET Discontinued 2025-09-02 2025-09-02 266368
TEVA-BETAHISTINE 16MG TABLET Discontinued 2025-09-02 2025-09-02 266371
TEVA-BETAHISTINE 24MG TABLET Discontinued 2025-09-02 2025-09-02 266374
TEVA-CANDESARTAN 8MG TABLET Discontinued 2025-05-28 2025-05-28 258724

Showing 161 to 180 of 435